IGF-1R ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER.

• 收藏
• 分享

专利权人:

PIERRE FABRE MEDICAMENT

发明人:

BEAU-LARVOR, Charlotte,BROUSSAS, Matthieu,CHAMPION, Thierry,GOETSCH, Liliane,HAEUW, Jean-François,PEREZ, Michel,RILATT, Ian,ROBERT, Alain

申请号：

TN2016000472

公开号：

TN2016000472A1

申请日:

2015.04.27

申请国别(地区):

TN

年份:

2018

代理人:

摘要：

The present invention relates to an antibody-drug-conjugate capable of binding IGF-lR. From one aspect, the invention relates to an antibody-drug-conjugate comprising an antibody capable of binding to IGF-lR, said antibody being conjugated to at least one drug selected from derivatives of dolastatin 10 and auristatins. The invention also comprises method of treatment and the use of said antibody-drug- conjugate for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/